Bausch And Lomb (BLCO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Bausch and Lomb Corp  (NYSE: BLCO)
 

Bausch And Lomb Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Jun 30 2026, Bausch And Lomb Corp has not recorded any inventories.
Visit Bausch And Lomb Corp Balance sheet

Within Healthcare sector 253 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1088 in the first quarter 2026, to 1535.

BLCO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bausch And Lomb Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLCO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -4.95 % -5.24 % -5.79 % -10.19 % -1.68 %
Y / Y Cost of Sales Growth - 0.21 % 6.61 % 9.7 % 8.51 %
Inventory Turnover Ratio (TTM) - 2.04 2.01 1.95 1.86
BLCO's Total Ranking # 1535 # 1088 # 509 # 989 # 387
Average inventory processing period - 179 181 187 197
Seq. Inventory Growth 2.25 % 0.1 % -2.89 % -4.38 % 1.94 %
Seq. Cost of Sales Growth - -9.4 % 4.52 % -2.68 % 8.73 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 254
Overall Market # 1535

Inventory Turnover Ratio Statistics
High Average Low
2.48 2 1.54
(Dec 31 2022)   (Jun 30 2026)



BLCO Company Profile >> Back to BLCO Efficiency Comparisons >> Compare BLCO Inventory Turnover Ratio to its Competitors

Financial Statements
Bausch And Lomb's Inventories $ 999 Millions Visit BLCO's Balance sheet
Bausch And Lomb's Cost of Revenues TTM $ 1,523 Millions Visit BLCO's Income Statement
What are BLCO's Sales? Visit BLCO's Sales by Segment

Other Inventory Turnover Ratios
Bausch And Lomb's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BLCO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BLCO's Competitors
Inventory Turnover Ratio for BLCO's Suppliers
Inventory Turnover Ratio for BLCO's Customers

You may also want to know
BLCO's Sales Growth Rates BLCO's Pe Price to earnings ratio BLCO's Receivables Turnover Ratio BLCO's Stock Quote
BLCO's Net Income Growth Rates BLCO's Ps Price to Sales ratio BLCO's Sales per Employee BLCO's Asset Turnover Ratio
BLCO's Net Margin BLCO's Pb Price to Book ratio BLCO's Financial Strength Ratios BLCO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions

Date modified: 2026-08-13T07:52:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.